IP Verse

Ready-To-Use Bortezomib Solution

Patent No. EP3324937 (titled "Ready-To-Use Bortezomib Solution") was filed by Stada Arzneimittel on Jul 21, 2016. The application was issued on Aug 17, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREMay 17, 2023TER MEER STEINMEISTER & PARTNER
EXTROVISMay 16, 2023BREUER
NEDERLANDSCH OCTROOIBUREAUMay 16, 2023NEDERLANDSCH OCTROOIBUREAU
GRUNDMay 15, 2023GRUND
STRAWMANMay 12, 2023VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
CONSILIENT HEALTHApr 24, 2023ELKINGTON AND FIFE
EVER VALINJECTAug 18, 2022GASSNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3324937

STADA ARZNEIMITTEL
Application Number
EP16744351A
Filing Date
Jul 21, 2016
Status
Granted And Under Opposition
Jul 15, 2022
Publication Date
Aug 17, 2022
External Links
Slate, Register , Google Patents